A point-of-care assay for genotyping women prior to ovarian stimulation with recombinant or human menopausal gonadotropins in assisted reproduction
Puntos clave
Genotyping of FSHR N680S using a rapid LAMP assay enables informed treatment decisions.
The LAMP assay provides results quickly, streamlining processes in reproductive healthcare settings.
Assessment using a user-friendly LAMP assay indicates improved outcomes for women undergoing IVF.
This innovation highlights the potential for personalized reproductive treatment plans in clinical practice.
Resumen
The LAMP assay provides a rapid and user-friendly genotyping of the FSHR N680S, which makes it a valuable tool in point-of-care settings, where it may help guide treatment options prior to IVF.
Un ensayo en el punto de atención para genotipar mujeres antes de la estimulación ovárica con gonadotropinas menopáusicas recombinantes o humanas en reproducción asistida | Synapse